第 1 到 35 筆結果,共 35 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Develop companion radiopharmaceutical YKL40 antibodies as potential theranostic agents for epithelial ovarian cancer | Chang, Ming-Cheng; Chiang, Ping-Fang; Kuo, Yu-Jen; Peng, Cheng-Liang; I-CHUN CHEN ; Huang, Chia-Yen; CHI-AN CHEN ; YING-CHENG CHIANG | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 1 | 1 | |
2 | 2021 | A DNA Damage Response Gene Panel for Different Histologic Types of Epithelial Ovarian Carcinomas and Their Outcomes | YING-CHENG CHIANG ; PO-HAN LIN ; TZU-PIN LU ; KUAN-TING KUO ; YI-JOU TAI ; HENG-CHENG HSU ; CHIA-YING WU ; Lee, Chia-Yi; Shen, Hung; CHI-AN CHEN ; WEN-FANG CHENG | Biomedicines | 3 | 3 | |
3 | 2021 | Increased risk of second primary malignancies among endometrial cancer survivors receiving surgery alone: A population-based analysis | YEN-LING LAI ; CHUN-JU CHIANG ; YU-LI CHEN ; You, San-Lin; Chen, Yun-Yuan; YING-CHENG CHIANG ; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEN-FANG CHENG | Cancer medicine | 3 | 3 | |
4 | 2019 | Developing a Prognostic Gene Panel of Epithelial Ovarian Cancer Patients by a Machine Learning Model | TZU-PIN LU ; KUAN-TING KUO ; Chen, Ching-Hsuan; Chang, Ming-Cheng; Lin, Hsiu-Ping; Hu, Yu-Hao; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN | Cancers | 17 | 14 | |
5 | 2019 | Immune checkpoint Ab enhances the antigen-specific anti-tumor effects by modulating both dendritic cells and regulatory T lymphocytes | Sun N.-Y.; U-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEI-ZEN SUN ; CHUNG-LIANG CHIEN ; WEN-FANG CHENG | Cancer Letters | 12 | 13 | |
6 | 2019 | Bevacizumab dose affects the severity of adverse events in gynecologic malignancies | Lee S.-P.; HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Frontiers in Pharmacology | 15 | 17 | |
7 | 2019 | Impact of adjuvant modalities on survival in patients with advanced stage endometrial carcinoma: A retrospective analysis from a tertiary medical center | YI-JOU TAI ; HENG-CHENG HSU ; YING-CHENG CHIANG ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | International Journal of Environmental Research and Public Health | 9 | 8 | |
8 | 2019 | Blockade of PD-L1 enhances cancer immunotherapy by regulating dendritic cell maturation and macrophage polarization | Sun N.-Y.; YU-LI CHEN ; Wu W.-Y.; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; YI-JOU TAI ; HENG-CHENG HSU ; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancers | 39 | 38 | |
9 | 2019 | CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells | Lin H.-W.; YING-CHENG CHIANG ; Sun N.-Y.; YU-LI CHEN ; Chang C.-F.; YI-JOU TAI ; CHI-AN CHEN ; WEN-FANG CHENG | Endocrine-Related Cancer | 12 | 13 | |
10 | 2018 | CDH1, DLEC1 and SFRP5 methylation panel as a prognostic marker for advanced epithelial ovarian cancer | Lin, Han-Wei; Fu, Chi-Feng; Chang, Ming-Cheng; TZU-PIN LU ; Lin, Hsiu-Ping; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | Epigenomics | 10 | 9 | |
11 | 2018 | Immuno-modulators enhance antigen-specific immunity and anti-tumor effects of mesothelin-specific chimeric DNA vaccine through promoting DC maturation | YU-LI CHEN ; Chang M.-C.; YING-CHENG CHIANG ; Lin H.-W.; Sun N.-Y.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Cancer Letters | 32 | 29 | |
12 | 2018 | Factors predicting parametrial invasion in patients with early-stage cervical carcinomas | HENG-CHENG HSU ; YI-JOU TAI ; YU-LI CHEN ; YING-CHENG CHIANG ; CHI-AN CHEN ; WEN-FANG CHENG | PLoS ONE | 14 | 14 | |
13 | 2018 | Irradiation Enhances Abscopal Anti-tumor Effects of Antigen-Specific Immunotherapy through Regulating Tumor Microenvironment | Chang M.-C.; YU-LI CHEN ; Lin H.-W.; YING-CHENG CHIANG ; Chang C.-F.; Hsieh S.-F.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Molecular Therapy | 31 | 28 | |
14 | 2017 | Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study | YING-CHENG CHIANG ; Chen Y.-Y.; Hsieh S.-F.; CHUN-JU CHIANG ; You S.-L.; WEN-FANG CHENG ; Lai M.-S.; CHI-AN CHEN ; Taiwan Cervical Cancer Prevention Surveillance Center | Taiwanese Journal of Obstetrics and Gynecology | 12 | 13 | |
15 | 2017 | Risk factors of hypersensitivity to carboplatin in patients with gynecologic malignancies | Tai Y.-H.; YI-JOU TAI ; HENG-CHENG HSU ; Lee S.-P.; Chen Y.-Y.; YING-CHENG CHIANG ; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG | Frontiers in Pharmacology | 10 | 9 | |
16 | 2016 | Mesothelin-specific cell-based vaccine generates antigen-specific immunity and potent antitumor effects by combining with IL-12 immunomodulator | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; Chen T.-C.; Tang Y.-C.; CHI-AN CHEN ; WEI-ZEN SUN ; WEN-FANG CHENG | Gene Therapy | 16 | 16 | |
17 | 2016 | Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine | Chang M.-C.; YU-LI CHEN ; YING-CHENG CHIANG ; YA-JUNG CHENG ; Jen Y.-W.; CHI-AN CHEN ; WEN-FANG CHENG ; WEI-ZEN SUN | American Journal of Cancer Research | 9 | ||
18 | 2015 | Standardized uptake value and apparent diffusion coefficient of endometrial cancer evaluated with integrated whole-body PET/MR: Correlation with pathological prognostic factors | I-LUN SHIH ; RUOH-FANG YEN ; CHI-AN CHEN ; BANG-BIN CHEN ; Wei S.-Y.; WEN-CHUN CHANG ; BOR-CHING SHEU ; WEN-FANG CHENG ; YAO-HUI TSENG ; Chen X.-J.; CHI-HAU CHEN ; LING-HUNG WEI ; YING-CHENG CHIANG ; PAO-LING TORNG ; MEN-LUH YEN ; TIFFANY TING-FANG SHIH | Journal of Magnetic Resonance Imaging | 44 | 38 | |
19 | 2015 | Molecular alterations in endometrial and ovarian clear cell carcinomas: Clinical impacts of telomerase reverse transcriptase promoter mutation | Huang H.-N.; YING-CHENG CHIANG ; WEN-FANG CHENG ; CHI-AN CHEN ; Lin M.-C.; KUAN-TING KUO | Modern Pathology | 25 | 22 | |
20 | 2015 | Gene methylation profiles as prognostic markers in ovarian clear cell and endometrioid adenocarcinomas | CHI-AN CHEN ; YING-CHENG CHIANG ; Chang M.-C.; Hu Y.-H.; You S.-L.; Cheng Y.-Y.K.; Chou C.-Y.; WEN-FANG CHENG | American Journal of Translational Research | 8 | ||
21 | 2015 | Overexpression of CHI3L1 is associated with chemoresistance and poor outcome of epithelial ovarian carcinoma | YING-CHENG CHIANG ; Lin H.-W.; Chang C.-F.; Chang M.-C.; Fu C.-F.; Chen T.-C.; Hsieh S.-F.; CHI-AN CHEN ; WEN-FANG CHENG | Oncotarget | 26 | 26 | |
22 | 2015 | Outcome of patients with recurrent adult-type granulosa cell tumors - A Taiwanese Gynecologic Oncology Group study | Wang P.-H.; Sun H.-D.; Lin H.; Wang K.-L.; Liou W.-S.; Hung Y.-C.; YING-CHENG CHIANG ; Lu C.-H.; Lai H.-C.; Chang T.-C.; Yen M.-S.; CHI-AN CHEN ; Lai C.-H.; Yu M.-S.; Chou C.-Y.; Chang C.-L.; Huang K.-F.; Ho C.-M.; Chu T.-Y.; Wang P-H.; Liu F-S.; Kan Y.-Y.; Wu C.-H.; Taiwanese Gynecologic Oncology Group | Taiwanese Journal of Obstetrics and Gynecology | 11 | 11 | |
23 | 2015 | Establishment of a New Ovarian Cancer Cell Line CA5171 | YING-CHENG CHIANG ; WEN-FANG CHENG ; Chang M.-C.; TZU-PIN LU ; KUAN-TING KUO ; Lin H.-P.; CHANG-YAO HSIEH ; CHI-AN CHEN | Reproductive Sciences | 5 | 6 | |
24 | 2013 | Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan | YING-CHENG CHIANG ; CHI-AN CHEN ; CHUN-JU CHIANG ; Hsu T.-H.; Lin M.-C.; You S.-L.; WEN-FANG CHENG ; Lai M.-S. | Journal of Gynecologic Oncology | 86 | 89 | |
25 | 2013 | High-risk human papillomavirus, other than type 16/18, in predominantly older Taiwanese women with high-grade cervical preinvasive lesions | YING-CHENG CHIANG ; WEN-FANG CHENG ; YU-LI CHEN ; Chang M.-C.; CHANG-YAO HSIEH ; Lin M.-C.; CHI-AN CHEN | Taiwanese Journal of Obstetrics and Gynecology | 9 | 9 | |
26 | 2013 | Epigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients | YING-CHENG CHIANG ; Chang M.-C.; Chen P.-J.; Wu M.-M.; CHANG-YAO HSIEH ; WEN-FANG CHENG ; CHI-AN CHEN | Endocrine-Related Cancer | 19 | 19 | |
27 | 2012 | Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects | Chang M.-C.; CHIEN-NAN LEE ; YU-LI CHEN ; YING-CHENG CHIANG ; WEI-ZEN SUN ; Hu Y.-H.; CHI-AN CHEN ; WEN-FANG CHENG | Clinical Science | 11 | 11 | |
28 | 2012 | Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response | YU-LI CHEN ; Chang M.-C.; Huang C.-Y.; YING-CHENG CHIANG ; Lin H.-W.; CHI-AN CHEN ; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Oncology | 107 | 103 | |
29 | 2012 | Mesothelin enhances invasion of ovarian cancer by inducing MMP-7 through MAPK/ERK and JNK pathways | Chang M.-C.; CHI-AN CHEN ; Chen P.-J.; YING-CHENG CHIANG ; YU-LI CHEN ; TSUI-LIEN MAO ; Lin H.-W.; Lin Chiang W.-H.; WEN-FANG CHENG | Biochemical Journal | 113 | 112 | |
30 | 2012 | New primers for methylation-specific polymerase chain reaction enhance specificity of detecting STAT1 methylation | Chang M.-C.; YING-CHENG CHIANG ; Ho C.-M.; YU-LI CHEN ; CHI-AN CHEN ; WEN-FANG CHENG ; Chou C.-Y. | Taiwanese Journal of Obstetrics and Gynecology | 5 | 4 | |
31 | 2011 | Impact of various treatment modalities on the outcome of stage IB1-IIA cervical adenocarcinoma | YU-LI CHEN ; Ho C.-M.; CHI-AN CHEN ; YING-CHENG CHIANG ; Huang C.-Y.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Gynecology and Obstetrics | 6 | 6 | |
32 | 2010 | Metronomic chemotherapy enhances antitumor effects of cancer vaccine by depleting regulatory T lymphocytes and inhibiting tumor angiogenesis | CHI-AN CHEN ; Ho C.-M.; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; Syu M.-H.; CHANG-YAO HSIEH ; WEN-FANG CHENG | Molecular Therapy | 82 | 72 | |
33 | 2009 | Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects | CHI-AN CHEN ; Chang M.-C.; WEI-ZEN SUN ; YU-LI CHEN ; YING-CHENG CHIANG ; CHANG-YAO HSIEH ; Chen S.M.; PO-NI HSIAO ; WEN-FANG CHENG | Gene Therapy | 15 | 13 | |
34 | 2009 | High mesothelin correlates with chemoresistance and poor survival in epithelial ovarian carcinoma | WEN-FANG CHENG ; Huang C.-Y.; Chang M.-C.; Hu Y.-H.; YING-CHENG CHIANG ; YU-LI CHEN ; CHANG-YAO HSIEH ; CHI-AN CHEN | British Journal of Cancer | 117 | 112 | |
35 | 2008 | Synchronous primary cancers of the endometrium and ovary | YING-CHENG CHIANG ; CHI-AN CHEN ; Huang C.-Y.; CHANG-YAO HSIEH ; WEN-FANG CHENG | International Journal of Gynecological Cancer | 58 | 54 |